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INTRODUCTION
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The remaining population included all adults who were not dispensed ADHD medication nor had an ADHD or ASD diagnosis in the NPR. Parents of adults with and without ADHD/ASD were also identified through the MBRN and included in the analyses to account for parental factors associated with ADHD, ASD and other psychiatric disorders (e.g. socio-demographic factors, pregnancy-related factors and parental psychiatric disorders), and to account for relatedness.
Outcome Diagnoses
We studied the following major comorbid psychiatric disorders typically diagnosed in late adolescence and adulthood (42), all registered in the NPR at 18 years or more: anxiety disorder (ICD-10 codes; F40-F42), major depressive disorder (MDD; F32-F33), bipolar disorder (BD; F30-F31), personality disorders (PD; F60-F61), with a separate analysis on anti-social personality disorder (F60.2) (only included in the main analyses because of a small number of cases),
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
7 schizophrenia spectrum disorder (SCZ; F20-F29) and substance use disorder (SUD; F10-F19).
For BD, we also included those who were dispensed lithium during 2004-2015, according to NorPD.
Summary Statistics from large-scale GWAS
Summary statistics from the large-scale GWAS for the psychiatric disorders examined (10, (43) (44) (45) (46) (47) (48) (49) (50) (51) , were downloaded from the LDHub GWAS share centre (http://ldsc.broadinstitute.org/gwashare/) (52). To date, no GWAS has examined the genetics of individuals diagnosed with both ADHD and ASD. Combining the existing data from individual GWAS on ADHD and ASD, respectively, would result in associations heavily biased towards the larger study. Thus, we analysed ADHD and ASD only separately.
Since not all data are publically available, and no large-scale, well-powered GWAS were performed on all disorders examined, we used some proxy traits. In lack of adequate genetic data on personality disorders, we combined the data from the five GWAS on the five NEO-personality traits (Neuroticism, Extraversion, Openness to experience, Agreeableness and Conscientiousness) (53) using the inverse variance method in METAL software (54). Since all five NEO-personality traits were analyzed in the same-sized samples, there was no bias towards any of the traits. We also used the trait "anti-social behavior" as a proxy for anti-social personality disorder (49). As proxies for SUD, we used smoking behavior (ever vs never smoked) (51) and alcohol dependence (AD) (50).
In all analyses, we restricted the examined data to single nucleotide polymorphisms (SNPs) of good imputation quality (INFO ≥ 0.8), minor allele frequency ≥ 1% (common variation), and the data was derived from individuals of European descent only.
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Statistical Analyses
We estimated prevalence ratios (PR) using Poisson regression with robust standard errors (55) to examine the associations of ADHD, ASD and ADHD+ASD with other psychiatric disorders, using the remaining adult population as reference. To adjust for potential confounders, we performed two regression models, including the following covariates; Model I: Birth year, maternal marital status, maternal age and paternal age in years at delivery, parents' highest attained level of education at record linkage, the individual's gestational age in weeks and gestational age-and sex-specific birthweight z-scores (56) Analyses were performed on the total sample and stratified by sex. Our main analyses were based on the multiplicative scale using relative effect measures, however, when assessing sex differences, we supplemented the analyses with absolute effect measures. For this, we estimated prevalence differences of psychiatric disorders between men and women with and without either ADHD, ASD or ADHD+ASD using predicted prevalences from a Poisson regression model with adjustment for birth year (5-year periods). Significance of interaction by sex on the multiplicative scale was evaluated by comparing Poisson regression models with and without the interaction term (gender x ADHD) included, tested by likelihood ratio tests, and interaction by sex on the additive scale was evaluated using relative excess risk due to interaction (RERI) (57).
Two-sided tests with a significance threshold of p<0.05 were employed in all analyses.
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Analyses were carried out with PASW Statistics 23 (58) and STATA intercooled v.14 (59) from November 3, 2017 to March 13, 2019.
Genetic correlations (r g ) were calculated using linkage disequilibrium score regression (LDSC) that quantifies the similarities in genetic architecture between two traits by evaluating the relationship between SNP association strengths and genetic linkage disequilibrium (8) . Due to sample overlap between the examined datasets, the correlations were calculated without constraining the intercept. To calculate if the genetic correlations in the ADHD group were significantly different from those in the ASD group, we applied the following formula
where "rg1" refers to the genetic correlation between a comorbidity and ADHD, "rg2" refers to the genetic correlation between the same comorbid disorder and ASD, "a" refers to SE of "rg1" estimate and "b" refers to SE of "rg2" estimate. The significance was calculated using a two tailed Z-test. To account for multiple testing, Bonferroni correction was applied to the significant threshold of 0.05, bringing the adjusted significance threshold to 0.00625.
Sensitivity Analyses
We conducted several sensitivity analyses to evaluate the robustness of our results. We reran all the analyses 1) excluding individuals with a diagnosis of intellectual disability, 2) excluding all with comorbid SCZ when analysing BD and SUD, 3) excluding all individuals with SUD when analysing SCZ, and 4) only including individuals who had their psychiatric diagnosis registered at least twice in the NPR. Missing values in covariates (6% for gestational age and birthweight z-scores, < 1% for other variables) were handled by list-wise deletion in the main analyses. In the sensitivity analyses, we also used multiple imputation with chained equations (60) to evaluate possible bias due to missing information in gestational age when adjusting for M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 10 covariates. The outcome variables, all specified covariates and also birthweight, maternal preeclampsia and mother's chronic diseases (yes/no) were used for this information.
RESULTS
Study Population
Among the 1,701,206 individuals included in the study, we identified 38,636 adults (2.3% of the population; 45% women) with ADHD, 7,528 (0.4%; 27.9% women) with ASD, 1,467 (0.1%; 28.8% women) with ADHD+ASD and 1,653,575 (97.2%; 49% women) adults in the remaining population. In 2015, the mean ages of the ADHD, ASD and ADHD+ASD groups were 31, 26 and 27 years, respectively, compared to 33 years in the remaining population (Table 1) . Among parents, significantly more mothers of individuals with ASD and ADHD+ASD had the highest level of education compared to the ADHD group and the remaining population, likely explained by mothers to individuals with ASD/ADHD+ASD being born later in our study period, in a time where high education was more common. In addition, being diagnosed with at least one psychiatric disorder was more prevalent among parents of individuals in all exposure groups, compared to the remaining population (Table 1) .
Psychiatric comorbidity in adults with either ADHD, ASD or ADHD+ASD
Comorbid psychiatric disorders were two to 14 times more common in adults with ADHD, ASD or ADHD+ASD than in the remaining population (Table 2) . Overall, the PRs differed significantly between adults with ADHD and ASD for all psychiatric disorders studied. Relative to the remaining population, the association with BD was the strongest and with MDD the weakest in adults with ADHD (PRs: 7.1; 95% CI 6.8-7.4 and 3.7; 95% CI 3.6-3.8, respectively), M A N U S C R I P T
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11 while the association with SCZ was the strongest and with SUD the weakest in adults with ASD (PRs 13.9; 95% CI 12.7-15.2 and 1.9; 95% CI 1.7-2.2, respectively) ( Table 2 , model II). The associations with anxiety, BD, MDD, PD and SUD were significantly stronger in adults with ADHD than with ASD (p<0.001 for all), with SUD revealing a particularly pronounced difference (PR ADHD : 6.2 versus PR ASD : 1.9). The association with SCZ, however, was stronger in adults with ASD than with ADHD (PRs 13.9 versus 4.4, p <0.001).
In the ADHD+ASD group, the PRs ranged from 3.6 (95% CI 3. 
Sex-specific results
When stratifying on sex, patterns of psychiatric comorbidity corresponded to those in the total sample ( Figure 1 / Supplemental, Table S2/S3). In both men and women, PR estimates for SCZ were significantly larger in ASD or ADHD+ASD than in ADHD, while for SUD, estimates were significantly larger for ADHD or ADHD+ASD than for ASD. For anxiety, the PR estimates were significantly larger in men than in women for all exposure groups, and for SCZ, the PR was significantly larger in women with ASD than in men with ASD.
When evaluating associations and interactions on the additive scale, sex differences were more pronounced, and the prevalence difference estimates were significantly different between women and men with ADHD for all the disorders studied, while only for three disorders in adults with ASD ( Figure 2 /Supplemental, Table S4 ). Further, the associations were reversed, and prevalence M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 12 of most psychiatric disorders increased more in women than men in all exposure groups except for SUD and SCZ, where men in all exposure groups showed the highest prevalence increase.
Genetic Correlations
As shown in Figure 3 , the patterns of genetic correlations (r g ) were similar to those of the PRs for psychiatric comorbidities based on the epidemiological data. The two proxies for SUD revealed significantly stronger correlations with ADHD than with ASD ( Figure 3B /Supplemental, Table   S5 ). For SCZ, the r g estimate with ASD was almost twice as large as that with ADHD (r g(ASD+SCZ) : 0.211 (SE: 0.048, p<0.0001), r g(ADHD+SCZ) : 0.127 (SE: 0.036, p=0.0004)), but this difference was not statistically significant (p=0.16). The differences in genetic correlations between ADHD and ASD with the examined comorbid disorders were only statistically significant for the SUD-proxies and for the NEO-personality dimensional traits (Supplemental, Table S5 ).
Sensitivity Analyses
When we excluded individuals with intellectual disability, the results changed only for ASD, where the PR for SCZ increased slightly (PR crude 15.1; 95% CI 13.9-16.4 to PR sensitivity 16.5; 95% CI 15.1-18.1). For the ADHD and the ADHD+ASD groups, there were no substantial changes.
All the other sensitivity analyses yielded results that were very similar to those of the main analyses (Supplemental , Table S6/Table S7 ).
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DISCUSSION
In this first nationwide population-based study combining epidemiological data on adults with ADHD only, ASD only or both diagnoses, together with corresponding genetic data, we found different patterns of psychiatric comorbidities between the groups, overall and also when stratifying by sex. These patterns were also reflected in the genetic correlations, however, only proxies for two of the six traits showed a significant difference between ADHD and ASD. We also found that adults with both ADHD and ASD confer severe additional psychiatric morbidity relative to adults with either ADHD or ASD alone.
When comparing ADHD and ASD in our epidemiological data, we observed significant differences in the associations with all psychiatric comorbidities examined, with individual estimates being consistent with previous studies (11-13, 15, 24, 30-32) . The most marked differences were found for SCZ and SUD, where SCZ was more common in adults with ASD, and SUD more common in adults with ADHD. Associations with anxiety, BD and personality disorders were strongest in adults with both ADHD and ASD, indicating that this group of adults suffers from more severe impairments than those with ADHD or ASD only (61). This is supported by previous studies in children (32, 62) . Further, we found that adults with both ADHD and ASD had a similar increase in risk for SCZ as adults with ASD only, which, as far as we know, has not been shown before. To our knowledge, only one other population-based study reports on prevalences of psychiatric disorders among individuals with either ADHD, ASD or ADHD+ASD compared to unaffected individuals in the same population (33). However, this population was young (mean age ranging from 13.6 to 18. The sex differences in risk of psychiatric comorbidities were different among adults with ADHD and ASD, both on the relative and absolute scales. The present findings for adults with ADHD are also presented in our previous publication (19), and confirmed by a recent Swedish study (70) . Sex differences are strongly dependent on the scale used for analyses; with stronger associations for most psychiatric comorbidities in men than women on the relative scale, and stronger in women than men on the absolute scale. This may be explained by the lower prevalence in psychiatric disorders among men than women in the reference group, which has a profound influence on the relative effect measures, but not on the risk differences. We suggest that the smaller sex differences observed in adults with ASD than ADHD may partly be explained by the larger male:female ratio in adults with ASD and partly by women with ASD struggling more to communicate internalizing symptoms than women with ADHD (71, 72).
The behavioural patterns in the individuals of the two phenotypically different disorders also lead to different interactions with their environments. The differences in the associations with SUD between ADHD and ASD may partly be due to the ADHD-associated novelty-seeking and impulsive behaviour, increasing the risk of developing SUD to a larger degree in ADHD than in ASD, where a rigid and norm-abiding behaviour, with limited social contact, may be relatively
protective (30, 73, 74) . Thus, both genetic and environmental risk factors, as well as their interactions, may alter the expression of genes, and affect the structure and function of molecular networks in the brain, and thereby modify the risk to ADHD and ASD (32).
Strengths and Limitations
To our knowledge, this is the largest population-based study comparing psychiatric comorbidity in adults with ADHD, ASD or both, conducted so far. The analyses were also stratified according to sex and included genetic correlations in the interpretation. We used data from nationwide, population-based registries with compulsory notification, thus reducing selection bias to a minimum. As our patient groups were large enough to allow us to study individuals with either ADHD alone, ASD alone or both combined, we were able to study differences between more homogeneous groups.
We designed our study specifically to examine an adult population, allowing all participants to reach the typical age of diagnosis of the conditions investigated (42). Notably, this study covers the first birth cohort for which ASD became prevalent enough in adulthood to enable such a study to be performed. Further, it may be argued that adults with ADHD or ASD could more easily get other psychiatric diagnoses because they are already in touch with the health care system (81).
However, all adults with severe psychiatric disorders are likely to be in touch with secondary health care throughout life, independent of underlying neurodevelopmental disorders (82) .
With regard to the genetic correlations, it is important to note that their estimations are highly dependent on the sample size of the utilized GWAS. In addition, because there are no large-scale GWAS with freely available summary statistics for some of the examined comorbidities, proxy phenotypes were examined. Furthermore, patients' comorbidities are not always taken into account in the genetic studies, although individuals with known combined ADHD and ASD were excluded from some studies (43). Currently, psychiatric genetics are lacking GWAS on patients with comorbidities or with specific symptoms of psychiatric M A N U S C R I P T
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disorders, which limits our ability to examine the genetic variability that may be responsible for the diverse clinical landscape of psychiatric disorders.
Conclusions
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Statistical analyses
To adjust for potential confounders, we performed two regression models, including the Table S7 . Prevalence ratios of psychiatric disorders comparing adults with and without ADHD or ASD, using missing imputation for gestational age and sex-specific birth weight by gestational age z-scores M A N U S C R I P T
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